Biotech innovation: diversified basket, momentum leaders, cut losers
Biotech Breakout
| Symbol | Action | Vol | Stop Loss | Take Profit | Size | Links |
|---|---|---|---|---|---|---|
| IONS | BUY | 46% | 36.0% below entry | 12.4% above entry | 3.6% | TVYH |
| XBI | BUY | 27% | 20.7% below entry | 7.2% above entry | 6.2% | TVYH |
| IBB | BUY | 21% | 16.7% below entry | 5.8% above entry | 7.7% | TVYH |
| BBH | BUY | 20% | 15.8% below entry | 5.4% above entry | 8.1% | TVYH |
| BIIB | BUY | 31% | 24.0% below entry | 8.3% above entry | 5.3% | TVYH |
| REGN | BUY | 35% | 27.5% below entry | 9.5% above entry | 4.7% | TVYH |
| LLY | BUY | 38% | 29.7% below entry | 10.3% above entry | 4.3% | TVYH |
| MRK | BUY | 27% | 21.3% below entry | 7.3% above entry | 6.0% | TVYH |
| AMGN | BUY | 27% | 20.8% below entry | 7.2% above entry | 6.2% | TVYH |
| ISRG | BUY | 32% | 25.0% below entry | 8.6% above entry | 5.1% | TVYH |
| ABBV | BUY | 26% | 20.6% below entry | 7.1% above entry | 6.2% | TVYH |
| GILD | BUY | 27% | 21.2% below entry | 7.3% above entry | 6.1% | TVYH |
This strategy has moderate long-term potential but requires monitoring. - Take profit: Rebalance when any position exceeds 2x its target weight. Trim back to target, redeploy to underweight positions. - Stop loss: NO price-based stop loss. This strategy recovered from -36% drawdown to return 79% long-term. - Exit rule: Review annually. Exit if strategy underperforms its benchmark for 3 consecutive years.